PubRank

Annibale Versari

Author PubWeight™ 29.18‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Omitting radiotherapy in early positron emission tomography-negative stage I/II Hodgkin lymphoma is associated with an increased risk of early relapse: Clinical results of the preplanned interim analysis of the randomized EORTC/LYSA/FIL H10 trial. J Clin Oncol 2014 1.93
2 Tocilizumab: a novel therapy for patients with large-vessel vasculitis. Rheumatology (Oxford) 2011 1.45
3 The predictive value of positron emission tomography scanning performed after two courses of standard therapy on treatment outcome in advanced stage Hodgkin's disease. Haematologica 2006 1.45
4 Positron emission tomography (PET): evaluation of chronic periaortitis. Arthritis Rheum 2005 1.29
5 Clinical features of polymyalgia rheumatica and giant cell arteritis. Nat Rev Rheumatol 2012 1.18
6 Respiratory gated PET/CT in a European multicentre retrospective study: added diagnostic value in detection and characterization of lung lesions. Eur J Nucl Med Mol Imaging 2012 1.06
7 Is (18)F fluorodeoxyglucose positron emission tomography useful to assess activity of myositis? J Rheumatol 2013 1.05
8 (18)F-fluorodeoxyglucose positron emission tomography in the diagnosis and followup of idiopathic retroperitoneal fibrosis. Arthritis Rheum 2005 1.05
9 Pretherapy metabolic tumour volume is an independent predictor of outcome in patients with diffuse large B-cell lymphoma. Eur J Nucl Med Mol Imaging 2014 0.96
10 Comparison of 18F-DOPA, 18F-FDG and 68Ga-somatostatin analogue PET/CT in patients with recurrent medullary thyroid carcinoma. Eur J Nucl Med Mol Imaging 2012 0.96
11 PET/CT assessment of neuroendocrine tumors of the lung with special emphasis on bronchial carcinoids. Tumour Biol 2014 0.95
12 Multicenter comparison of 18F-FDG and 68Ga-DOTA-peptide PET/CT for pulmonary carcinoid. Clin Nucl Med 2015 0.94
13 Rescue treatment with tocilizumab for Takayasu arteritis resistant to TNF-α blockers. Clin Exp Rheumatol 2012 0.89
14 Role of imaging in the diagnosis of large and medium-sized vessel vasculitis. Rheum Dis Clin North Am 2013 0.89
15 Metabolic tumour volumes measured at staging in lymphoma: methodological evaluation on phantom experiments and patients. Eur J Nucl Med Mol Imaging 2014 0.89
16 Brief report on the use of radiolabeled somatostatin analogs for the diagnosis and treatment of metastatic small-cell lung cancer patients. J Thorac Oncol 2013 0.88
17 18F-Fluorodeoxyglucose positron emission tomography for the assessment of myositis: a case series. Clin Exp Rheumatol 2012 0.86
18 Rituximab therapy for chronic periaortitis. Ann Rheum Dis 2012 0.86
19 Validation of (68)Ge/(68)Ga generator processing by chemical purification for routine clinical application of (68)Ga-DOTATOC. Nucl Med Biol 2008 0.85
20 Role of 18F-fluorodeoxyglucose positron emission tomography in the workup of retroperitoneal fibrosis. Clin Exp Rheumatol 2011 0.85
21 Positron emission tomography in the staging of patients with Hodgkin's lymphoma. A prospective multicentric study by the Intergruppo Italiano Linfomi. Ann Hematol 2007 0.84
22 Comparison of different positron emission tomography tracers in patients with recurrent medullary thyroid carcinoma: our experience and a review of the literature. Recent Results Cancer Res 2013 0.81
23 Development of a simple kit-based method for preparation of pharmaceutical-grade ⁶⁸Ga-DOTATOC. Nucl Med Commun 2015 0.78
24 Radiation protection procedures in 131I treatments for thyroid cancer in patients requiring hemodialysis. Nucl Med Commun 2014 0.78
25 Influence of cations on the complexation yield of DOTATATE with yttrium and lutetium: a perspective study for enhancing the 90Y and 177Lu labeling conditions. Nucl Med Biol 2011 0.78
26 Interleukin-6 as an inflammatory mediator and target of therapy in chronic periaortitis. Arthritis Rheum 2013 0.78
27 Images in cardiovascular medicine. Chronic periaortitis. Circulation 2008 0.78
28 Italian Association of Clinical Endocrinologists (AME) position statement: a stepwise clinical approach to the diagnosis of gastroenteropancreatic neuroendocrine neoplasms. J Endocrinol Invest 2014 0.78
29 Influence of different chelators on the radiochemical properties of a 68-Gallium labelled bombesin analogue. Nucl Med Biol 2013 0.78
30 Personnel exposure in labelling and administration of (177)Lu-DOTA-D-Phe1-Tyr3-octreotide. Nucl Med Commun 2011 0.77
31 Synthesis and characterization of (68)Ga-labeled curcumin and curcuminoid complexes as potential radiotracers for imaging of cancer and Alzheimer's disease. Inorg Chem 2014 0.77
32 Radiosynthesis of 68Ga-labelled DOTA-biocytin (68Ga-r-BHD) and assessment of its pharmaceutical quality for clinical use. Nucl Med Commun 2012 0.76
33 Efficacy of infliximab in a patient with refractory idiopathic retroperitoneal fibrosis. Clin Exp Rheumatol 2012 0.76
34 AME position statement: primary hyperparathyroidism in clinical practice. J Endocrinol Invest 2012 0.75
35 Use of 2-[18F]fluoro-2-deoxy-D-glucose positron emission tomography in patients with Hodgkin lymphoma in daily practice: a population-based study from Northern Italy. Leuk Lymphoma 2011 0.75
36 Ectopic mature cerebral tissue in the nasal cavity incidentally detected by 18F-FDG PET/CT. Clin Nucl Med 2015 0.75
37 Efficient automated one-step synthesis of 2-[18F]fluoroethylcholine for clinical imaging: optimized reaction conditions and improved quality controls of different synthetic approaches. Nucl Med Biol 2010 0.75
38 Isolated vasculitis of the lower extremities in a patient with polymyalgia rheumatica and giant cell arteritis. Clin Exp Rheumatol 2011 0.75
39 Extra-articular rheumatoid arthritis imaged by [18F]FDG-PET/CT. Acta Reumatol Port 2016 0.75
40 Semiautomated labelling and fractionation of yttrium-90 and lutetium-177 somatostatin analogues using disposable syringes and vials. Nucl Med Commun 2012 0.75
41 Clinical images: PET-CT and contrast-enhanced ultrasound in Takayasu's arteritis. Rheumatology (Oxford) 2013 0.75
42 Skin dose saving of the staff in 90Y/177Lu peptide receptor radionuclide therapy with the automatic dose dispenser. Nucl Med Commun 2016 0.75
43 The impact of 18F-deoxyglucose positron emission tomography on tumor staging, treatment strategy and treatment planning for radiotherapy in a department of radiation oncology. Tumori 2005 0.75